Position in NVS
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$1,010,217
+$57,974 QoQ
Shares Held
6,446
+3.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#613
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026KING LUTHER CAPITAL MANAGEMENT CORP holds $1,075,739,230 across 11 Drug Manufacturers - General names. NVS ranks #9 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
208,203 | $249,724,945 | |
| 2 | JNJ |
Johnson & Johnson
|
848,614 | $215,522,497 | |
| 3 | ABBV |
AbbVie Inc.
|
774,352 | $194,857,937 | |
| 4 | AMGN |
Amgen Inc
|
493,165 | $178,584,909 | |
| 5 | MRK |
Merck & Co., Inc.
|
1,087,068 | $139,688,238 | |
| 6 | PFE |
Pfizer Inc
|
2,498,042 | $60,152,851 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
596,244 | $34,355,579 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
8,888 | $1,122,909 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,010,217 | 6,446 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $952,243 | 6,234 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1,484,170 | 10,765 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $1,398,328 | 10,904 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $1,706,967 | 14,106 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $1,233,860 | 11,068 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $1,009,591 | 10,375 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $1,201,038 | 10,442 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $1,013,818 | 9,523 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $877,050 | 9,067 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $826,641 | 8,187 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $850,123 | 8,346 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $920,501 | 9,122 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $973,268 | 10,579 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $906,837 | 9,996 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $792,176 | 10,422 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $992,889 | 11,746 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $819,058 | 9,334 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $845,485 | 9,666 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $974,899 | 11,921 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $1,542,777 | 16,909 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $891,641 | 10,431 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $1,397,564 | 14,800 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,404,056 | 16,146 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,590,985 | 18,216 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $1,557,975 | 18,896 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||